Recro Pharma Inc
REPH
Get informed when a big investor buys or sells
+ FollowMarket Cap$177.42M
Close$
$2.58
23.5% upside
Current Fair Value
23.5% upsideUndervalued by 23.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $177.42 Million |
|---|---|
| Enterprise Value | $211.34 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.14 |
| Beta | 1.12 |
| Outstanding Shares | 95,229,192 |
Return
| Return on Equity | -22.63% |
|---|---|
| Return on Assets | -8.65% |
| Return on Invested Capital | -12.41% |
Valuation & Multiples
| P/E Ratio | -7.89 |
|---|---|
| PEG | 8.63 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.23 |
| Enterprise Value to EBIT | -16.46 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.72 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data